Single Chain Antibody Core

$107,963P01FY2008CANIH

Cleveland Clinic Lerner Com-Cwru, Cleveland OH

Investigators

Linked publications & trials

Paper 38888342 Paper 38861022 Paper 37982645 Paper 37658794 Paper 37607012 Paper 37268107 Paper 37036972 Paper 36240739 Paper 36216730 Paper 35389431 Paper 35316583 Paper 34933455 Paper 34799452 Paper 34795058 Paper 34365219 Paper 32926474 Paper 32778760 Paper 32759968 Paper 32682051 Paper 32532922 Paper 32323871 Paper 32231306 Paper 32060280 Paper 32051346 Paper 31896590 Paper 31832571 Paper 31745337 Paper 31727782 Paper 31337876 Paper 31036052 Paper 30976078 Paper 30958867 Paper 30710579 Paper 30683702 Paper 30578323 Paper 30352854 Paper 30035180 Paper 30013031 Paper 29983891 Paper 29750542 Paper 29581268 Paper 29563620 Paper 29531172 Paper 29496741 Paper 29381763 Paper 29320425 Paper 29229854 Paper 29070673 Paper 28990926 Paper 28821568 Paper 28561022 Paper 28223414 Paper 27852626 Paper 27815826 Paper 27631700 Paper 27628766 Paper 27178468 Paper 27137933 Paper 26998763 Paper 26958928 Paper 26921329 Paper 26431948 Paper 26414443 Paper 26355092 Paper 26347473 Paper 26344057 Paper 26341626 Paper 26337909 Paper 26195767 Paper 25767098 Paper 25736762 Paper 25503978 Paper 25266676 Paper 25217633 Paper 25201411 Paper 25071181 Paper 25033044 Paper 25028470 Paper 25024377 Paper 25022196 Paper 24920846 Paper 24905199 Paper 24816115 Paper 24790153 Paper 24766884 Paper 24752299 Paper 24715958 Paper 24379360 Paper 24362892 Paper 24082147 Paper 24065129 Paper 23995070 Paper 23990781 Paper 23904479 Paper 23904475 Paper 23904159 Paper 23797602 Paper 23376919 Paper 23142783 Paper 22851693

Abstract

This core will develop highly selective, high affinity antibodies to investigate coordinated cell signaling. Antibodies will be generated to distinguish active forms of target enzymes. The antibodies will be isolated from an established cDNA, single-chain immune library displayed on ribosomes. This library will be screened using modified peptides that mimic the effector regions of key signal proteins or, alternatively, full- length activated proteins. This objective will be fulfilled in two specific aims: 1. To maintain immune libraries, 2. To isolate single-chain antibodies to specific antigens.

View original record on NIH RePORTER →